Patient Management
Continuous remote monitoring and management for chronic and post-acute patients
Platform · Cloud SaaSCompany source
Company profile
About Biofourmis
Biofourmis partners with healthcare organizations to provide AI-driven solutions for remote patient monitoring and in-home care.
Company description Biofourmis official website
Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Work at Biofourmis?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- acute care conditions
- chronic conditions
- COVID-19
- post-acute care conditions
- pre-surgical optimization
Who it serves
- Health Systems
- Hospitals
- Life Science companies
- Payers
- Risk-bearing organizations
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Recorded integration context: EMR systems.
Geographic context
Marketsglobal markets · United States (25 states with licensed operations)
Company sourceOfficial website
Company milestones
Platform expansion
Merged with CopilotIQ in October 2024 to create first end-to-end platform for AI-driven in-home care. ActiGraph acquired Biofourmis Life Science Business in January 2025. Selected by AdventHealth for Whole-Person Care program in January 2025. Expanded partnership with Lee Health for remote patient monitoring and home-based hospital care in November 2024.
Partnerships
Recorded partners
- ActiGraph (acquired Life Science Business January 2025)
- AdventHealth
- CopilotIQ (merged October 2024)
- Lee Health
- over 50 global health systems and payers
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Biofourmis Platform
AI-driven connected technology platform for remote patient monitoring and care delivery
Platform · Cloud SaaSCompany source
Hospital at Home
Technology-enabled acute care delivery in patients' homes
Service · HybridCompany source
SNF at Home
Skilled nursing facility-level care delivered in the home setting
Service · HybridCompany source
Timely Discharge
Remote monitoring solution to facilitate safe and timely hospital discharge
Service · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Framework for Analytical Validation of DHT-Based Actigraphy and Signal Measures in HF Trials: The VALIDATE-HF Program.JACC. Heart failure · Apr 1, 2026
Digital Platform to Optimize Guideline-Directed Heart Failure Therapy: Results of the AIM-POWER Trial.Circulation. Heart failure · Feb 1, 2026
The Clinical Utility of Traditional and Machine Learning Alarms during the Care of Acutely Ill Patients.Applied clinical informatics · Jan 1, 2026
A Digital Platform to Optimize Guideline-Directed Heart Failure Therapy: Rationale and Design of the AIM-POWER Trial.Journal of cardiac failure · Dec 1, 2025
The role of continuous monitoring in acute-care settings for predicting all-cause 30-day hospital readmission: A pilot study.Heliyon · Jan 30, 2025
Personalized digital behaviour interventions increase short-term physical activity: a randomized control crossover trial substudy of the MyHeart Counts Cardiovascular Health Study.European heart journal. Digital health · Oct 1, 2023
Clinical validation
Clinical-trial records
Serum Potassium Prediction Using Machine Learning and Single-lead ECGNCT07493798 · Sponsor · WITHDRAWN
Prediction of Patient Deterioration Using Machine LearningNCT05045742 · Sponsor · COMPLETED
Prediction of 30-Day Readmission Using Machine LearningNCT04849312 · Sponsor · COMPLETED
Prediction of Expected Length of Hospital Stay Using Machine LearningNCT04784351 · Sponsor · WITHDRAWN
Digital Remote Home Monitoring for Heart FailureNCT05988749 · Mentioned · TERMINATED
Remote Monitoring in Cancer Care: A Platform StudyNCT05018208 · Mentioned · COMPLETED
Regulatory
Regulatory records
Biovitals Analytics EngineK183282 · 510k · Aug 15, 2019
RhythmAnalyticsK182344 · 510k · Mar 7, 2019
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
70% reduction in 30-day readmissions
Hospital at Home and remote patient management programs
21 hours earlier detection of deterioration
AI-driven predictive analytics
Up to 38% reduction in cost of care
Remote patient monitoring programs
80% reduction in notification burden
AI algorithms for clinician workflow optimization
4M+ data points captured per post-acute care patient per day
Precision treatment monitoring
AdventHealth
Support 'Whole-Person Care' with new Acute Care-at Home Program
Lee Health
Expansion of Remote Patient Monitoring and Introduction of Home Based Hospital Care
General outcomes across customers
Remote patient monitoring and care delivery across multiple health systems
70% reduction in 30-day readmissions, ability to detect deterioration 21 hours sooner, reductions in cost of care by up to 38%
General outcomes across health systems
Remote patient monitoring and hospital at home programs
70% reduction in 30-day readmissions, ability to detect deterioration 21 hours sooner, reductions in cost of care by up to 38%
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Maulik Majmudar, M.D.
Chief Medical Officer and Co-Founder
David Koretz
CEO
Lesa McArdle, DNP, RN, CENP
Assistant Vice President, Strategic Accounts & Consulting
Chen Hao
Vice President of Data Science
Maulik Majmudar
Co-founder and Chief Medical Officer
Mark NIU
Chief InfoSec. & Privacy Officer
Daniel Song
General Counsel
06 · Company updates
Updates from Biofourmis
Recent articles published on Biofourmis's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Remote Patient Monitoring & Wearables
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.